Imperial College of Science, Technology and Medicine [The] and DNAe Group Holdings Limited
Lead Participant:
IMPERIAL COLLEGE LONDON
Abstract
To develop a blood test-based molecular analysis technique for monitoring breast cancer patients for early evidence of recurrence of tumor DNA.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
IMPERIAL COLLEGE LONDON | £285,450 | £ 142,725 |
  | ||
Participant |
||
KTN LTD | ||
DNAE GROUP HOLDINGS LIMITED | ||
IMPERIAL COLLEGE LONDON |
People |
ORCID iD |